Esperion Therapeutics shares owned by Mackenzie Financial
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Mackenzie Financial
from 13F filings
Historical chart of Mackenzie Financial investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Mackenzie Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $723k | 273k | 2.65 |
| 2025-06-30 | $12k | 12k | 0.98 |
| 2025-03-31 | $177k | 123k | 1.44 |
| 2024-12-31 | $315k | 143k | 2.20 |
| 2024-09-30 | $109k | 66k | 1.65 |
| 2024-06-30 | $78k | 35k | 2.22 |
| 2024-03-31 | $46k | 17k | 2.68 |
| 2023-12-31 | $40k | 13k | 2.99 |
| 2023-09-30 | $32k | 33k | 0.97 |
| 2023-06-30 | $39k | 27k | 1.42 |
| 2023-03-31 | $139k | 87k | 1.59 |
| 2022-12-31 | $423k | 68k | 6.23 |